Ablation Technology Market

Ablation Technology Market: Evolution

The growing demand for minimally invasive treatments for atrial fibrillation has led to constant advancements in the ablation technology, opening new possibilities in the ablation market. Ablation of atrial fibrillation (AF) and ventricular tachycardia (VT) has constantly evolved to meet the safety and efficacy profile of procedures used in the patient population. Of note, the growing demand for techniques for ablation of ventricular arrhythmias.

A number of technologies have emerged that incorporate advanced catheter designs for AF ablation. Demand for balloon-based technologies and advances in navigation technologies are bolstering the prospects in the ablation technology market. Moreover, the growing adoption of high-resolution imaging techniques is a key trend boosting he outcomes of ablation technology.

Advancements in sensors have led to the development of catheters that can provide surgeons feedback on contact force during the ablation process. Such technological advancements have improved the decision making in interventional procedures in cardiology. New manipulation technologies such as remote navigation technologies are gaining popularity across the healthcare systems, thus boosting sales in the ablation technology market.

Ablation Technology Market: Drivers, Current Prospects, Lucrative Avenues

Atrial fibrillation (AF) is the most common arrhythmia diagnosed and has a marked comorbidity in elderly population. It affects at least 33.5 mn individuals around the world. In the U.S. alone, it is expected to affect 6–12 million people by 2050-end and 17.9 mn in Europe by the end of 2060. While on one hand, the reasons for the increase in the prevalence of AF are largely unknown, advancements in ablation technology market are crucial for survival after onset of AF. This is a key underpinning for extending lucrative prospects for medical device manufacturers and vendors in the ablation technology market. The global burden of AF has led to risk stratification, which has cemented the role of novel ablation technologies in multidisciplinary management of AF.

Ablation Technology Market: Competition Landscape and Key Developments

The past couple of decades has witnessed constant development of atrial fibrillation (AF) ablation technologies. Medical device manufacturers in the ablation technology market have leaned on adopting new approaches to ablation to be used in treating AF, one of the most common heart rhythm conditions prevalent worldwide.

Researchers pioneering in developing technologies for interventional medical specialties are conducting multi-center trials, which will propel the advent of safer and effective ablation technologies. One such research in the U.S. has demonstrated that a novel lattice-tip ablation catheter for performing point-by-point ablation generated outcome outcomes than radiofrequency ablation (RFA). The approach makes multiple lesions to stop abnormal heartrates (arrhythmias).

The researchers claimed to have conducted first-in-human trial in 2020, whose results were presented Heart Rhythm Society Annual Scientific Sessions. More such studies are ongoing for increasing the safety profile for the ablation procedure for atrial fibrillation. The results of the study have unarguably extended the horizon for the treatment of AF and managing its morbidities, thereby enriching prospects of the ablation technology market.

Some of the key players in the ablation technology market are Medtronic, plc., InMode, Dornier MedTech, Stryker, Varian Medical Systems, Olympus Corporation, Smith & Nephew plc., AtriCure, Inc., AngioDynamics, CONMED Corporation, Boston Scientific Corporation, Abbott, and Johnson & Johnson.

Ablation Technology Market: Regional Landscape

Europe and North America have been witnessing substantial lucrative prospects. Their growth has pivoted on the rising adoption of new ablation technologies in the treatment of AF. Relentless R&D in catheter design and imaging technologies to be used in VT ablation has also spurred the demand for ablation technology, thereby bolstering sales of products. The U.S. and the U.K. are key countries that have generated massive revenues to the global ablation technology market. The prevalence of AF and the rapidly aging population in the emerging economies around the world have played crucial role in expanding the revenue potential in recent years.